Ordinary Rebalance | Solactive Health Care Technology Index | Effective Date 14th March 2024
In the ordinary rebalance, the following composition will be implemented effective open 14.03.2024:
| ABBOTT LABORATORIES |
| AMGEN INC |
| BIONTECH SE |
| GETINGE AB CLASS B |
| GILEAD SCIENCES INC |
| GSK PLC-SPON ADR |
| JOHNSON & JOHNSON |
| MEDTRONIC PLC |
| MODERNA INC |
| PFIZER INC |
| QIAGEN NV |
| REGENERON PHARMACEUTICALS |
| SANOFI SA |
| TAKEDA PHARMACEUTICAL |
| THERMO FISHER SCIENTIFIC INC |
| VIR BIOTECHNOLOGY INC |
| WEST PHARMACEUTICAL SERVICES INC |